AnGes Inc
TSE:4563
AnGes Inc
Research & Development
AnGes Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AnGes Inc
TSE:4563
|
Research & Development
-¥5.6B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-17%
|
|
GNI Group Ltd
TSE:2160
|
Research & Development
-¥2.6B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Research & Development
-¥3.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Research & Development
-¥8.3B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-11%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Research & Development
-¥909m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-17%
|
|
S
|
StemRIM Inc
TSE:4599
|
Research & Development
-¥1.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
See Also
What is AnGes Inc's Research & Development?
Research & Development
-5.6B
JPY
Based on the financial report for Mar 31, 2024, AnGes Inc's Research & Development amounts to -5.6B JPY.
What is AnGes Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-17%
Over the last year, the Research & Development growth was 46%. The average annual Research & Development growth rates for AnGes Inc have been -15% over the past three years , -14% over the past five years , and -17% over the past ten years .